Some of these mechanisms are being targeted in clinical trials; however, none are presently curative and the molecular mechanisms of AR-dependence and the transition to apparent AR-indifference of almost all prostate cancers under APDT pressure are still not understood [3,4,5,7]. Here, AR is linked to Familial prostate cancer.